These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15568590)

  • 1. Primary prevention of sudden cardiac death. do we need to implant a defibrillator in all the patients with low ejection fraction?
    Disertori M; El-Sherif N
    Ital Heart J; 2004 Sep; 5(9):643-7. PubMed ID: 15568590
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
    Triedman JK
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
    [No Abstract]   [Full Text] [Related]  

  • 4. Sudden cardiac death risk stratification and assessment: primary prevention based on ejection fraction criteria.
    Saba S
    Heart Fail Clin; 2011 Apr; 7(2):175-83, vii. PubMed ID: 21439496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.
    Toma M; McAlister FA; Ezekowitz J; Kimber S; Gulamhusein S; Pantano A; Sivakumaran S; Cujec B; Paterson I; Armstrong PW
    Am J Cardiol; 2006 Mar; 97(6):882-5. PubMed ID: 16516594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
    Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death.
    Huikuri HV
    Europace; 2009 Dec; 11(12):1574. PubMed ID: 19933771
    [No Abstract]   [Full Text] [Related]  

  • 8. Implantable defibrillators and sudden cardiac death.
    Josephson M; Wellens HJ
    Circulation; 2004 Jun; 109(22):2685-91. PubMed ID: 15184292
    [No Abstract]   [Full Text] [Related]  

  • 9. Are complications of implantable defibrillators under-estimated and benefits over-estimated?
    Brignole M
    Europace; 2009 Sep; 11(9):1129-33. PubMed ID: 19578174
    [No Abstract]   [Full Text] [Related]  

  • 10. The editor's roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation.
    Friedewald VE; Fonarow GC; Olshansky B; Yancy CW; Roberts WC
    Am J Cardiol; 2011 Feb; 107(4):583-90. PubMed ID: 21295175
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk stratification for sudden cardiac death: should we juist consider ejection fraction?].
    Paolucci M; Cattafi G; Magenta G; Vecchi MR; Schirru M; Lunati M
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):27S-32S. PubMed ID: 19195303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?
    Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton AE; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders GD
    Int J Cardiol; 2014 Mar; 172(1):253-4. PubMed ID: 24467982
    [No Abstract]   [Full Text] [Related]  

  • 13. A prognostic index relating 24-hour ambulatory blood pressure to cardiac events in ischemic cardiomyopathy following defibrillator implantation.
    Antonini L; Colivicchi F; Pasceri V; Greco S; Varveri A; Turani L; Kol A; Santini M
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1089-94. PubMed ID: 18834457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of preimplantation cardiac imaging in patients referred for a primary-prevention implantable cardioverter-defibrillator.
    Krahn AD; Hoch JS; Rockx MA; Leong-Sit P; Gula LJ; Yee R; Skanes AC; Klein GJ
    Am J Cardiol; 2008 Sep; 102(5):588-92. PubMed ID: 18721517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefits.
    Jolly S; Dorian P; Alter DA
    J Eval Clin Pract; 2006 Apr; 12(2):190-5. PubMed ID: 16579828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pathway for sudden cardiac death prevention.
    Herzog E; Aziz EF; Kukin M; Steinberg JS; Mittal S
    Crit Pathw Cardiol; 2009 Mar; 8(1):1-6. PubMed ID: 19258831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implanted defibrillators and primary prevention of sudden cardiac death: where are we today?
    Ray IB; Reddy VY
    Int J Cardiol; 2005 Jan; 98(1):15-20. PubMed ID: 15676160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from a population: the limitations of left ventricular ejection fraction as the major determinant for primary prevention implantable cardioverter-defibrillators.
    Groh WJ
    J Am Coll Cardiol; 2006 Mar; 47(6):1167-8. PubMed ID: 16545647
    [No Abstract]   [Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.